• Home
  • Search Results

Search Results

Healthy Volunteers
643 studies match your search
Not currently enrolling

Mindset and Cognitive Control Study

Many students have beliefs about intelligence that can relate to their academic performance. Therefore, the purpose of this study is to investigate if the way students learn and adapt in the classroom varies as a function of their beliefs. Research on how beliefs influence student performance is sorely needed and of high priority.

Age & Gender
  • 18 years ~ 22 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Opinions and Perceptions
  • UNC Students (undergrad, grad, professional)
Not currently enrolling

Teaching the Tar Heel Bus Tour: Co-Developing a Racial Literacy Curriculum with NC Communities

In this project, we want to work with community partners to develop a curriculum for developing and teaching racial literacy. The content will recognize the legacies of racism and draw on the rich community-based experiences of the Tar Heel Bus Tour.

Age & Gender
  • 12 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
Not currently enrolling

Emotion and Physiology in Context (EPIC) Study

The purpose of this study is to use an MRI and other devices to observe the brain and body activity that happens when people feel certain emotions.

Age & Gender
  • 18 years ~ 80 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Brain, Head, Nervous System
  • Heart and Circulation
  • and 4 more

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-positive breast cancer

Purpose: Is the combination of T-DM1 and a newer drug tucatinib, better than usual treatment with T-DM1 alone at preventing your cancer from returning? Treatment with T-DM1 and placebo or T-DM1 and tucatinib, for up to 14 cycles, unless the breast cancer returns or the side effects become too severe. If the breast cancer returns while on the study, the treatment will be changed. After completion of T-DM1 and/or placebo, or T-DM1 and tucatinib, the study doctor will continue to follow the patients condition with clinic visits every 6 months for 10 years and watch for side effects and for signs of breast cancer returning.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Breast)
  • Sexual and/or Reproductive Health
  • Women's Health

Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer

The purpose of this study is to evaluate a new treatment routine for patients with metastatic HER2 -positive breast cancer. We want to find out what effects, good and bad, using a Poly (ADP-Ribose) polymerase (PARP) inhibitor called niraparib in combination with trastuzumab has on patients with metastatic HER2- positive breast cancer.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Breast)
Open

TBCRC-047-Avelumab With Binimetinib, Utomilumab, or Anti-OX40 Antibody PF-04518600 in Treating Triple Negative Breast Cancer (InCITe)

Have you ever been diagnosed with metastatic triple negative breast cancer and received 2 or less lines of chemotherapy for your metastatic disease? If so you may be eligible for a trial to evaluate different treatment combination with avelumab for your metastatic breast cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Breast)
Not currently enrolling

Study for Pregnant Women or Recently Pregnant Women with Medicaid

In this study, we want to interview women with pregnancy Medicaid in North Carolina. We would like to learn what would help more people go to the dentist and get dental care during this time. That way, we can make suggestions for policy changes to help more people get the care they need.

Age & Gender
  • 18 years ~ 99 years
  • Female, Gender Inclusive
Study Interest
  • Behavior
  • Minority Health
  • Opinions and Perceptions
  • and 8 more
Visit Location
100% Remote (online, phone, text)
Open

Embodied Behavior Study

Participants are asked to come into the lab for a 1.5-hour session. During this session they will complete questionnaires and tasks. Questionnaires will ask about physical and mental health, life experiences, emotions, and cognitive associations. Tasks are designed to measure participants' sensitivity to heartbeat and stomach sensations, as well as socioemotional functioning.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Eating, Nutrition, and Metabolism
  • Mental and Emotional Health
  • Sleep
Open

Physiology and Cognition (PAC)

Metabolism is the process your body uses to make energy. The main purpose of this study is to observe the impact of metabolic processes on cognition and behavior.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Eating, Nutrition, and Metabolism
  • Mental and Emotional Health
  • and 5 more
Not currently enrolling

Investigating the Feasibility of Fresh Whole Blood Transfusion Using an Untreated Syringe and the Potential Hemolysis Incited by Pressure Infusion through Needle-free IV Connector

Current practice in military blood transfusion is to use specific IV bags and chemical preservatives to transfer blood from the donor to the injured recipient. Our goal is to study if this blood transfusion can occur using a basic syringe without any preservative. This will help military personnel in areas will limited resources to provide blood transfusions to injured soldiers and save lives. We will also be evaluating ultrasound techniques which determine if a patient needs fluid (either regular IV fluid or blood transfusion).

Age & Gender
  • 18 years ~ 65 months
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
  • Injury/Injury Prevention
  • Veteran Health / Military
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research